Recombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed protein

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Bohr, Wilhelm ^a   Kupper, Michael ^b   Hoffmann, Kurt ^b   Weiskirchen, Ralf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; LUCIFERASE; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; BIOTECHNOLOGICAL PRODUCTION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHORETIC MOBILITY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PURIFICATION; RAT; REPORTER GENE; SUPERNATANT; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NEPHROBLASTOMA; PROTEIN BINDING;

RATTUS;

ANIMALS; CELL LINE; CELL PROLIFERATION; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; PROTEIN BINDING; RATS; RECOMBINANT PROTEINS; TRANSFECTION; WILMS TUMOR;

EID: 78651251525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016000     Document Type: Article

References (41)

1. Gressner OA, Weiskirchen R, Gressner AM (2007) Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol 6: 7.
2. Gressner AM, Weiskirchen R (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 10: 76-99.
3. Secker GA, Shortt AJ, Sampson E, Schwarz QP, Schultz GS, et al. (2008) TGFb stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling. Exp Cell Res 314: 131-142.
4. Leask A, Abraham DJ (2004) TGF-β signaling and the fibrotic response. FASEB J 18: 816-827.
5. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH (2000) CTGF expression is induced by TGF-β in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 32: 1805-1819.
6. Gressner OA, Lahme B, Demirci I, Gressner AM, Weiskirchen R (2007) Differential effects of TGF-β on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 47: 699-710.
7. Tong Z, Chen R, Alt DS, Kemper S, Perbal B, et al. (2009) Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology 50: 939-947.
8. Rachfal AW, Brigstock DR (2003) Connective tissue growth factor (CTGF/ CCN2) in hepatic fibrosis. Hepatol Res 26: 1-9.
9. Igarashi A, Okochi H, Bradham DM, Grotendorst GR (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4: 637-645.
10. Shiwen X, Rajkumar V, Denton CP, Leask A, Abraham DJ (2009) Pericytes display increased CCN2 expression upon culturing. J Cell Commun Signal 3: 61-64.
11. Phanish MK, Winn SK, Dockrell ME (2010) Connective tissue growth factor- (CTGF, CCN2)-a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol 114: e83-e92.
12. Weiskirchen R (2011) CCN proteins in liver health and disease. Front Biosci 16: 1939-1961.
13. Bork P (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327: 125-130.
14. Perbal B (2004) CCN proteins: multifunctional signalling regulators. Lancet 363: 62-64.
15. Grotendorst GR, Duncan MR (2005) Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19: 729-738.
16. Bradham DM, Igarashi A, Potter RL, Grotendorst GR (1991) Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294.
17. Brigstock DR (1999) The connective tissue growth factor/cysteine-rich 61/ nephroblastoma overexpressed (CCN) family. Endocr Rev 20: 189-206.
18. Perbal B (2001) NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 54: 57-79.
19. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, et al. (2000) Tumor necrosis factor α suppresses the induction of connective tissue growth factor by transforming growth factor-β in normal and scleroderma fibroblasts. J Biol Chem 275: 15220-15225.
20. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, et al. (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276: 10594-10601.
21. Leask A, Sa S, Holmes A, Shiwen X, Black CM, et al. (2001) The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts. Mol Pathol 54: 180-183.
22. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16: 585-601.
23. Arnott JA, Zhang X, Sanjay A, Owen TA, Smock SL, et al. (2008) Molecular requirements for induction of CTGF expression by TGF-β1 in primary osteoblasts. Bone 42: 871-885.
24. Sin WC, Tse M, Planque N, Perbal B, Lampe PD, et al. (2009) Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization. J Biol Chem 284: 29935-29944.
25. Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, et al. (2009) CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol 174: 1725-1734.
26. Soret J, Dambrine G, Perbal B (1989) Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells. J Virol 63: 1803-1807.
27. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, et al. (1992) Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis- associated virus type 1-induced nephroblastomas. Mol Cell Biol 12: 10-21.
28. Lin CG, Leu SJ, Chen N, Tebeau CM, Lin SX, et al. (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278: 24200-24208.
29. Lin CG, Chen CC, Leu SJ, Grzeszkiewicz TM, Lau LF (2005) Integrindependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J Biol Chem 280: 8229-8237.
30. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, et al. (2001) Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54: 293-299.
31. van Roeyen CR, Eitner F, Scholl T, Boor P, Kunter U, et al. (2008) CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation. Kidney Int 73: 86-94.
32. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, et al. (1998) Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100.
33. Edgell CJ, McDonald CC, Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80: 3734-3737.
34. Kunzmann S, Seher A, Kramer BW, Schenk R, Schütze N, et al. (2008) Connective tissue growth factor does not affect transforming growth factor-β1- induced Smad3 phosphorylation and T lymphocyte proliferation inhibition. Int Arch Allergy Immunol 147: 152-160.
35. Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, et al. (2009) Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat 16: 612-620.
36. Kang D, Gho YS, Suh M, Kang C (2002) Highly sensitive and fast protein detection with Coomassie Brilliant Blue in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Bull Korean Chem Soc 23: 1511-1512.
37. Hirosawa M, Hoshida M, Ishikawa M, Toya T (1993) MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci 9: 161-167.
38. Borkham-Kamphorst E, Stoll D, Gressner AM, Weiskirchen R (2004) Inhibitory effect of soluble PDGF-β receptor in culture-activated hepatic stellate cells. Biochem Biophys Res Comm 317: 451-462.
39. Chen Q, Miller LJ, Dong M (2010) Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor. Am J Physiol Endocrinol Metabol 299: E62-E68.
40. Karger A, Fitzner B, Brock P, Sparmann G, Emmrich J, et al. (2008) Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. Cell Signal 20: 1865-1872.
41. Rietsch A, Beckwith J (1998) The genetics of disulfide bond metabolism. Ann Rev Genet 32: 163-184.